drugset / Trial / NCT02078310

Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia

NCT02078310

Phase 1/2 Completed 35 enrolled Intra-Cellular Therapies, Inc.
RandomizedParallel-groupQuadruple-blindBasic science

Summary

A Phase 1b/2, Randomized, Double-blind, Placebo-Controlled, Multiple Oral Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients with Dementia

Timeline

Start
2014-02
Primary completion
2014-08
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumateperone Small molecule 20 mg Oral

Indications